| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4645538
Max Phase: Preclinical
Molecular Formula: C13H18N4S2
Molecular Weight: 294.45
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CC(CN)Nc1cc(CS)cc2sc(C(=N)N)cc12
Standard InChI: InChI=1S/C13H18N4S2/c1-7(5-14)17-10-2-8(6-18)3-11-9(10)4-12(19-11)13(15)16/h2-4,7,17-18H,5-6,14H2,1H3,(H3,15,16)
Standard InChI Key: QYPDCDACLUDSPR-UHFFFAOYSA-N
Associated Targets(Human)
SFN Tbio 14-3-3 protein sigma (29 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 294.45 | Molecular Weight (Monoisotopic): 294.0973 | AlogP: 2.37 | #Rotatable Bonds: 5 |
| Polar Surface Area: 87.92 | Molecular Species: BASE | HBA: 5 | HBD: 5 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 10.23 | CX Basic pKa: 9.72 | CX LogP: 1.40 | CX LogD: -2.29 |
| Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.33 | Np Likeness Score: -0.56 |
References
| 1. Guillory X, Wolter M, Leysen S, Neves JF, Kuusk A, Genet S, Somsen B, Morrow JK, Rivers E, van Beek L, Patel J, Goodnow R, Schoenherr H, Fuller N, Cao Q, Doveston RG, Brunsveld L, Arkin MR, Castaldi P, Boyd H, Landrieu I, Chen H, Ottmann C.. (2020) Fragment-based Differential Targeting of PPI Stabilizer Interfaces., 63 (13): [PMID:32501690] [10.1021/acs.jmedchem.9b01942] |
Source
Source(1):